Abstract: Among other things, the present disclosure provides technologies for stereoselective preparation chiral compounds. In some embodiments, prepared chiral compounds are useful for chirally controlled preparation of oligonucleotides. In some embodiments, such oligonucleotides target transcripts associate with various conditions, disorders or diseases.
| # | Name | Date |
|---|---|---|
| 1 | 202417063190-STATEMENT OF UNDERTAKING (FORM 3) [21-08-2024(online)].pdf | 2024-08-21 |
| 2 | 202417063190-REQUEST FOR EXAMINATION (FORM-18) [21-08-2024(online)].pdf | 2024-08-21 |
| 3 | 202417063190-POWER OF AUTHORITY [21-08-2024(online)].pdf | 2024-08-21 |
| 4 | 202417063190-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [21-08-2024(online)].pdf | 2024-08-21 |
| 5 | 202417063190-FORM 18 [21-08-2024(online)].pdf | 2024-08-21 |
| 6 | 202417063190-FORM 1 [21-08-2024(online)].pdf | 2024-08-21 |
| 7 | 202417063190-DRAWINGS [21-08-2024(online)].pdf | 2024-08-21 |
| 8 | 202417063190-DECLARATION OF INVENTORSHIP (FORM 5) [21-08-2024(online)].pdf | 2024-08-21 |
| 9 | 202417063190-COMPLETE SPECIFICATION [21-08-2024(online)].pdf | 2024-08-21 |
| 10 | 202417063190-Proof of Right [05-09-2024(online)].pdf | 2024-09-05 |
| 11 | 202417063190-FORM 3 [19-02-2025(online)].pdf | 2025-02-19 |